Surgical treatment possibilities of drug-resistant Ménière‘s disease
Authors:
S. Brennerová 1*; Z. Balatková 1*
; R. Černý 2; V. Koucky 1; V. Bandurová 1; V. Svobodová 1; M. Bonaventurová 4; M. Komarc 3; J. Plzák 1; Z. Čada 1
Authors place of work:
Klinika otorinolaryngologie a chirurgie, hlavy a krku 1. LF UK a FN Motol, Praha
1; Neurologická klinika, 2. LF UK a FN Motol, Praha
2; Ústav biofyziky a informatiky, 1. LF UK v Praze
3; Oddělení otorinolaryngologie, Fakultní Thomayerova nemocnice, v Praze
4
Published in the journal:
Cesk Slov Neurol N 2021; 84/117(3): 263-268
Category:
Original Paper
doi:
https://doi.org/10.48095/cccsnn2021263
Summary
Aim: Ménière‘s disease is one of the most common paroxysmal disorders of the peripheral vestibular system. Treatment is mainly pharmacological. Treatment differs for acute attacks and the period between the attacks. If pharmacological treatment fails, chemical labyrinthectomy or surgical treatment is being used. The aim of this study was to determine the success of surgical treatment by comparing objective and subjective methods. Patients and methods: In a group of patients operated on for drug-resistant Ménière‘s disease, we evaluated the preoperative and postoperative results of the video-Head Impulse Test and caloric test with video oculographic recording. The Dizziness Handicap Inventory questionnaire was used for the subjective evaluation of symptoms. Results: Postoperatively, there is a statistically significant caloric hyporefl exia or areflexia in the operated ear (P < 0.05), while for the video-Head Impulse Test there was no significant difference observed in any of the monitored parameters before and after surgery (P > 0.05). After surgery, patients had a better quality of life from the perspective of dizziness according to the questionnaire survey. A significant difference in all evaluated parameters (P < 0.05) was observed. Conclusion: Using surgical treatment for Ménière‘s disease, it is possible to influence vestibular attacks with a significant improvement in the quality of life of patients. According to the results of the study, it seems to be useful to evaluate the postoperative condition by a combination of the caloric test and questionnaire methods.
Keywords:
Ménière‘s disease – chemical labyrintectomy – surgical labyrintectomy – neurectomy – video-Head Impulse Test – caloric test – Dizziness Handicap Inventory questionnaire
Zdroje
1. Čada Z, Černý R, Čakrt O et al. Závratě. Havlíčkův Brod: Tobiáš; 2017.
2. Oberman BS, Cureoglu S, Isildak H. The aetio-pathologies of Meniere’s disease: a contemporary review. Acta Otorhinolaryngologica Italica 2017; 37(4): 250–263. doi: 10.14639/ 0392-100X-793.
3. Lopez-Escamez JA, Carey J, Chung WH et al. Diagnostic criteria for Menière‘s disease according to the Classification Committee of the Bárány Society. HNO 2017; 65(11): 887–893. doi: 10.1007/ s00106-017-0387-z.
4. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere‘s disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113(3): 181–185. doi: 10.1016/ S0194-5998(95)70102-8.
5. Doucek Abboudová H, Vodička J, Vincent O. První zkušenosti se zobrazením vnitřního ucha magnetickou rezonancí s využitím intratympanické aplikace kontrastní látky. Otorinolaryngol Foniatr 2015; 64(1): 28–34.
6. Li X, Wu Q, Sha Y et al. Gadolinium-enhanced MRI reveals dynamic development of endolymphatic hydrops in Meniere‘s disease. Braz J Otorhinolaryngol 2020; 86(2): 165–173. doi: 10.1016/ j.bjorl.2018.10.014.
7. Doucek Abboudová H, Vodička J, Vincent O. Přínos magnetické rezonance v diagnostice Ménièrovy choroby. Otorinolaryngol Foniatr 2020; 69(3): 116–121.
8. Claes J, Van de Heyning PH. Medical treatment of Meniere‘s disease: a review of literature. Acta Otolaryngol 1997; 526 (Suppl): 37–42. doi: 10.3109/ 00016489709 124019.
9. De Luca P, Cassandro C, Ralli M et al. Dietary restriction for the treatment of Meniere‘s disease. Transl Med UniSa 2020; 22: 5–9.
10. Rah YC, Han JJ, Park J et al. Management of intractable Meniere‘s disease after intratympanic injection of gentamicin. Laryngoscope 2015; 125(4): 972–978. doi: 10.1002/ lary.25009.
11. Nedzelski JM, Schessel DA, Bryce GE et al. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere‘s disease. Am J Otol 1992; 13(1): 18–22.
12. Kroese AB, Das A, Hudspeth AJ. Blockage of the transduction channels of hair cells in the bullfrog‘s sacculus by aminoglycoside antibiotics. Hear Res 1989; 37(3): 203–217. doi: 10.1016/ 0378-5955(89)90023-3.
13. Silverstein H, Wazen J, Van Ess MJ et al. Intratympanic gentamicin treatment of patients with Meniere‘s disease with normal hearing. Otolaryngol Head Neck Surg 2010; 142(4): 570–575. doi: 10.1016/ j.otohns.2009.12.009.
14. Huang TS. Endolymphatic sac surgery for Meniere‘s disease: experience with over 3,000 cases. Otolaryngol Clin North Am 2002; 35(3): 591–606. doi: 10.1016/ s0030-6665(02)00027-0.
15. Salzman R, Stárek I, Kamarád V et al. Chirurgická léčba Ménièrovy nemoci: naše zkušenosti s dekompresí endolymfatického vaku. Otorinolaryngol Foniatr 2016; 62(4): 232–236.
16. Pullens B, Verschuur HP, van Benthem PP. Surgery for Meniere‘s disease. Cochrane Database Syst Rev 2013; 2013(2): CD005395. doi: 10.1002/ 14651858.CD005395. pub3.
17. Alarcon AV, Hidalgo LO, Arevalo RJ et al. Labyrinthectomy and Vestibular Neurectomy for Intractable Vertig inous Symptoms. Int Arch Otorhinolaryngol 2017; 21(2): 184–190. doi: 10.1055/ s-0037-1599242.
18. Gacek RR , Gacek MR. Comparison of labyrinthectomy and vestibular neurectomy in the control of vertigo. Laryngoscope 1996; 106 (2 Pt 1): 225–230. doi: 10.1097/ 00005537-199602000-00023.
19. Monsell EM, Wiet RJ, Young NM et al. Surgical treatment of vertigo with retrolabyrinthine vestibular neurectomy. Laryngoscope 1988; 98 (8 Pt 1): 835–839. doi: 10.1288/ 00005537-198808000-00009.
20. Leveque M, Seidermann L, Tran H et al. Vestibular function outcomes after vestibular neurectomy in Meniere disease: can vestibular neurectomy provide complete vestibular deafferentation? Auris Nasus Larynx 2010; 37(3): 308–313. doi: 10.1016/ j.anl.2009.06.006.
21. Schlegel M, Vibert D, Ott SR et al. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Meniere‘s disease. Otol Neurotol 2012; 33(8): 1380–1385. doi: 10.1097/ MAO.0b013e318268 d1cd.
22. Koucký V, Černý R, Balatková Z et al. Chirurgická terapie oboustranné farmakorezistentní Menièrovy choroby. Cesk Slon Neurol N 2019; 82/ 115(6): 689–692. doi: 10.14735/ amcsnn2019689.
23. Gardner G, Robertson JH. Hearing preservation in unilateral acoustic neuroma surgery. Ann Otol Rhinol Laryngol 1988; 97(1): 55–66. doi: 10.1177/ 000348948809700110.
24. Oliveira LN, Oliveira CL, Lopes KC et al. Diagnostic assessment of patients with Meniere‘s disease through caloric testing and the video-head-impulse test. Braz J Otorhinolaryngol 2019; S1808-8694(19)30141-7. doi: 10.1016/ j.bjorl.2019.10.008
25. McGarvie LA, Curthoys IS, MacDougall HG et al. What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Meniere‘s disease? Acta Otolaryngol 2015; 135(9): 859–865. doi: 10.3109/ 00016489.2015.1015606.
26. Halmagyi GM, Chen L, MacDougall HG et al. The Video Head Impulse Test. Front Neurol 2017; 8: 258. doi: 10.3389/ fneur.2017.00258.
27. Šichnárek J, Mrázková E, Záthurecký E et al. Video Head Impulse Test – nejnovější metoda vyšetření vestibulárního aparátu. Otorinolaryngol Foniatr 2019; 68(2): 103–108.
Štítky
Paediatric neurology Neurosurgery NeurologyČlánok vyšiel v časopise
Czech and Slovak Neurology and Neurosurgery
2021 Číslo 3
- Advances in the Treatment of Myasthenia Gravis on the Horizon
- Memantine Eases Daily Life for Patients and Caregivers
- Spasmolytic Effect of Metamizole
Najčítanejšie v tomto čísle
- Developmental dysphasia – functional and structural correlations
- Guidelines on intravenous thrombolysis in the treatment of acute cerebral infarction – 2021 version
- Ethylenglycol poisoning
- Surgical treatment possibilities of drug-resistant Ménière‘s disease